Price$92.75+1.24 (+1.36%)
01:45 PM07:30 PM
News · 26 weeks67-79%
2026-02-012026-07-26
Mix3890d
- Insider21(55%)
- Other7(18%)
- SEC Filings5(13%)
- Leadership3(8%)
- Earnings2(5%)
Latest news
25 items- PREstablishment Labs® to Announce Second Quarter 2026 Financial Results on August 6Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2026, before the market opens on Thursday, August 6, 2026, and will host a conference call at 8:30 AM ET that day to discuss those results. To participate in the conference call, Dial: (+1) 888-396-8049 (US & Canada) / (+1) 416-764-8646 (international). The call will also be available via live or archived webcast on the "Investor Relations" section of the Establishment Labs website at www.establishmentlabs.com About Establishment L
- INSIDERDirector Chacon Quiros Juan Jose was granted 11,315 shares, increasing direct ownership by 25% to 56,508 units (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- INSIDERSEC Form 4 filed by Director Lewin Nicholas Sheridan4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- INSIDERAmendment: Director Harris Taylor C. was granted 3,722 shares (SEC Form 4)4/A - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- INSIDERDirector Gillin Leslie was granted 196 shares, increasing direct ownership by 1% to 18,594 units (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- INSIDERDirector Custin Ann was granted 239 shares, increasing direct ownership by 0.99% to 24,325 units (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- INSIDERDirector Lewin Nicholas Sheridan was granted 291 shares, increasing direct ownership by 0.03% to 1,079,960 units (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- INSIDERDirector Schutter Edward J was granted 216 shares, increasing direct ownership by 0.12% to 177,952 units (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- INSIDERDirector Slotkin Bryan was granted 189 shares, increasing direct ownership by 0.58% to 32,799 units (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- PRA Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics OpportunityIssued on behalf of Conexeu Sciences Inc. Conexeu Sciences Inc. (NASDAQ:CNXU) opened a new research and development facility at adMare BioInnovations’ M4 Innovation Centre, expanding the home of its CXU™ regenerative tissue platform, a single technology the company is designing to scale across soft-tissue restoration markets spanning aesthetics and body contouring, wound care, and breast reconstruction. RENO, Nev., July 01, 2026 (GLOBE NEWSWIRE) -- Biotech Insider, Medical aesthetics has become one of the most closely watched corners of healthcare, drawing established pharmaceutical and device makers into soft-tissue restoration, contouring, and reconstruction. Against that backdrop,
- INSIDERDirector Harris Taylor C. was granted 3,230 shares (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- INSIDERSEC Form 3 filed by new insider Harris Taylor C.3 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- SECEstablishment Labs Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Filer)
- PREstablishment Labs® Appoints Taylor Harris to Board of DirectorsEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced today the appointment of Taylor Harris to its Board of Directors. Mr. Harris brings more than 25 years of experience in corporate finance, executive leadership and board governance across healthcare, medical technology and life sciences companies. He currently serves on the board of directors of Procept BioRobotics and previously served as a director of Omada Health and Endologix. Most recently, he served as Chief Executive Officer of Cutera, Inc. Prior to Cutera, Mr. Harris served as Chief
- PRThe Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for ItIssued on behalf of Conexeu Sciences Inc. With Galderma now presenting clinical data on treating medication-driven facial volume loss, the GLP-1 aesthetics category has gone mainstream — and Conexeu Sciences Inc. (NASDAQ:CNXU) is positioning its regenerative CXU™ platform to compete for it. NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Biotech Insider — In emerging medical markets, the most telling signal is not the small company making the bold claim — it is the giant quietly proving the claim is real. That is exactly what has happened in aesthetics. Galderma, the pure-play dermatology leader behind Sculptra and Restylane, has been presenting interim clinical data demonstrating that i
- PREstablishment Labs® Added to Membership of U.S. Small-Cap Russell 2000® IndexEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, will be added as a member of the US small-cap Russell 2000® Index, effective when the US market opens on June 29th as part of the 2026 Russell indexes reconstitution. Membership in the Russell 2000® Index, which remains in place for half a year beginning 2026, is based on membership in the broad-market Russell 3000® Index. The stock was also automatically added to the appropriate growth and value indexes. Russell indexes are widely used by investment managers and institutional investors for index fund
- PRFresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma FirepowerIssued on behalf of Conexeu Sciences Inc.A clutch of new directors with Fortune 500 finance, M&A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.RENO, Nev., June 16, 2026 /CNW/ -- American News Group News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a promising platform into a real business. The names a young company recruits in that window say a great deal about its ambitions. On June 1
- INSIDERSee footnote 3 Jw Asset Management, Llc sold $6,636,886 worth of shares (90,533 units at $73.31) (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- PRAfter Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast InsteadConexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months matter. NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- Biotech Insider News Commentary — For more than fifty years, breast reconstruction has mostly meant one thing: replacement. A silicone shell, filled with gel, designed to restore shape and volume, none of them designed to regenerate the breast's own living tissue. That gap has consequences. Roughly two-thirds of the more than 100,000 women in the United States who undergo a mastectomy ea
- INSIDERDirector Schutter Edward J was granted 2,354 shares, increasing direct ownership by 1% to 177,736 units (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- INSIDERDirector Slotkin Bryan was granted 2,354 shares, increasing direct ownership by 8% to 32,610 units (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- INSIDERDirector Custin Ann was granted 2,354 shares, increasing direct ownership by 11% to 24,086 units (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- INSIDERDirector Lewin Nicholas Sheridan was granted 2,354 shares, increasing direct ownership by 0.22% to 1,079,669 units (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- INSIDERDirector Gillin Leslie was granted 2,354 shares, increasing direct ownership by 15% to 18,398 units (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
- INSIDERLarge owner Jw Asset Management, Llc sold $1,466,333 worth of shares (20,579 units at $71.25) (SEC Form 4)4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
ESTA FAQ
7 questionsWhat does Establishment Labs Holdings Inc. do?
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through...Where does ESTA stock trade?
Establishment Labs Holdings Inc. (ESTA) is listed on NASDAQ.What sector and industry is ESTA in?
Establishment Labs Holdings Inc. operates in the Health Care sector, Industrial Specialties industry.When did Establishment Labs Holdings Inc. go public?
Establishment Labs Holdings Inc. (ESTA) completed its IPO in 2018.What are analysts saying about ESTA?
Establishment Labs Holdings Inc. has had 8 recent analyst actions on file. The most recent action was from Canaccord Genuity: Buy on 2025-08-20. Recent price targets cluster around $4800.00.What companies are similar to ESTA?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare ESTA side-by-side with any of them on Quantisnow.How can I track ESTA on Quantisnow?
Quantisnow aggregates Establishment Labs Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ESTA to receive live email and push alerts on every new disclosure.